- Home
- PG vs ABBV Comparison
PG vs ABBV Comparison
Compare PG & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PG
- ABBV
- Stock Information
- Founded
- PG 1837
- ABBV 2012
- Country
- PG United States
- ABBV United States
- Employees
- PG N/A
- ABBV N/A
- Industry
- PG Package Goods/Cosmetics
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- PG Consumer Discretionary
- ABBV Health Care
- Exchange
- PG Nasdaq
- ABBV Nasdaq
- Market Cap
- PG 379.5B
- ABBV 333.8B
- IPO Year
- PG N/A
- ABBV N/A
- Fundamental
- Price
- PG $167.47
- ABBV $191.93
- Analyst Decision
- PG Buy
- ABBV Strong Buy
- Analyst Count
- PG 19
- ABBV 21
- Target Price
- PG $180.53
- ABBV $209.60
- AVG Volume (30 Days)
- PG 7.4M
- ABBV 6.5M
- Earning Date
- PG 01-22-2025
- ABBV 01-31-2025
- Dividend Yield
- PG 2.39%
- ABBV 3.46%
- EPS Growth
- PG 5.09
- ABBV N/A
- EPS
- PG 6.27
- ABBV 2.39
- Revenue
- PG $84,346,000,000.00
- ABBV $56,334,000,000.00
- Revenue This Year
- PG $4.47
- ABBV $7.21
- Revenue Next Year
- PG $3.28
- ABBV $7.50
- P/E Ratio
- PG $26.79
- ABBV $79.48
- Revenue Growth
- PG 0.49
- ABBV 3.71
- 52 Week Low
- PG $153.52
- ABBV $153.58
- 52 Week High
- PG $180.43
- ABBV $207.32
- Technical
- Relative Strength Index (RSI)
- PG 53.08
- ABBV 69.81
- Support Level
- PG $165.21
- ABBV $182.15
- Resistance Level
- PG $169.38
- ABBV $191.77
- Average True Range (ATR)
- PG 2.46
- ABBV 3.90
- MACD
- PG 0.76
- ABBV 2.22
- Stochastic Oscillator
- PG 75.37
- ABBV 95.20
About PG Procter & Gamble Company (The)
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, generating more than $80 billion in annual sales. It operates with a lineup of leading brands, including more than 20 that generate north of $1 billion each in annual global sales, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent more than half of the firm's consolidated total.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).